SCHEDULE: Farallon Capital Discloses Stake in InflaRx N.V.

Farallon Capital Management and its affiliated entities have reported beneficial ownership of over 5% of InflaRx N.V.'s ordinary shares.

Summary

• This filing is a Schedule 13G, indicating that Farallon Capital Management and its associated entities collectively beneficially own more than 5% of the outstanding shares of InflaRx N.V.
• The filing details the beneficial ownership of various Farallon Capital funds and individuals, including Farallon Capital Partners, L.P., Farallon Capital Institutional Partners, L.P., and others.
• The total aggregate amount beneficially owned by the reporting persons is 14,200,500 shares, representing 9.7% of the class of securities.
• The filing specifies shared voting power and shared dispositive power for all reporting persons, with sole voting and dispositive power being zero for most entities.
• The reporting persons are filing this statement pursuant to Rule 240.13d-1(c) and certify that the securities were not acquired or held for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of beneficial ownership and does not contain operational or financial performance information.

Future Outlook

The filing does not contain forward-looking statements or guidance. It is a disclosure of beneficial ownership.

Management Comments

• Each of the Farallon General Partner, the FCIP V General Partner, the F5MI General Partner and the Farallon Individual Reporting Persons hereby disclaims any beneficial ownership of any such Shares.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and hedge funds like Farallon Capital Management to disclose significant passive holdings in publicly traded companies. This filing indicates a substantial passive investment in InflaRx N.V.

Stakeholder Impact

• Shareholders: The disclosure of a significant stake by a large investment firm like Farallon Capital may influence market perception and potentially lead to increased trading volume or price volatility.
• Management and Board of Directors: The filing signifies a notable passive investment, which the company's leadership will be aware of as they manage corporate strategy and governance.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, InflaRx N.V., Farallon Capital Management, Securities Filing, Investment Holding, Ordinary Shares